IL17F and COVID-19: Given that SARS‐CoV‐2 infection specifically up‐regulates IL‐17F signalling and aryl hydrocarbon receptor signalling (Z. Zhou, Ren, et al., 2020), PGE2 is assumed to promote inflammatory Th17 cell expansion and function in COVID‐19.